Anticoagulation and Thrombolysis
Clinics in Chest Medicine · 2026-12 · 47 (4) · 747-757
DOI: 10.1016/j.ccm.2026.07.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Chest Medicine, 2026-12. Verfasst von Michael Q Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Electronic address: michael.dong@jefferson.edu. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Anticoagulants, Pulmonary Embolism, Fibrinolytic Agents. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
Pulmonary embolism is a life-threatening condition requiring prompt anticoagulation to prevent clot propagation and recurrence. Risk stratification guides therapy, with systemic thrombolysis reserved for high-risk patients and selected intermediate-high risk cases due to significant bleeding risk. Direct oral anticoagulants are preferred for most low and intermediate-low risk patients, while low-molecular-weight heparin and unfractionated heparin remain critical for higher- risk or procedurally complex cases. Emerging strategies including low-dose thrombolysis, catheter-directed therapies, and the future use of Factor XI inhibitors may improve safety without compromising efficacy. Management of bleeding complications necessitates rapid intervention, reversal when available, and coordinated multidisciplinary care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Electronic address: michael.dong@jefferson.edu.
- Department of Pharmacy, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA.
- Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
- Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Thrombosis & Haemostasis, Guy's & St Thomas' NHS Foundation Trust, London, UK.
- Department of Internal Medicine/ Cardiology, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA.
Zitieren
APA
Dong, M. Q., Ahuja, T., Merli, G., Rosovsky, R. P., Hunt, B. J., Horowitz, J. M., & West, F. M. (2026). Anticoagulation and Thrombolysis. Clinics in Chest Medicine, 47(4), 747-757. https://doi.org/10.1016/j.ccm.2026.07.007
Vancouver
Dong MQ, Ahuja T, Merli G, Rosovsky RP, Hunt BJ, Horowitz JM, et al. Anticoagulation and Thrombolysis. Clinics in Chest Medicine. 2026;47(4):747-757. doi:10.1016/j.ccm.2026.07.007
BibTeX
@article{Dong2026,
author = {Dong, Michael Q and Ahuja, Tania and Merli, Geno and Rosovsky, Rachel P and Hunt, Beverley J and Horowitz, James M and West, Frances Mae},
title = {Anticoagulation and Thrombolysis},
journal = {Clinics in Chest Medicine},
year = {2026},
volume = {47},
number = {4},
pages = {747--757},
doi = {10.1016/j.ccm.2026.07.007}
}
EUVIMED